Getinge AB (publ) (GNGBF) Stock

About Getinge AB (publ)

Getinge AB (publ) is a global provider of medical products and integrated solutions, primarily serving operating rooms, intensive care units, and sterilization departments. The company operates through three key segments: Acute Care Therapies, Life Science, and Surgical Workflows. Its diverse product lineup includes advanced sterile transfer and processing systems, washers, isolators, and sterilizers, complemented by logistical automation tools. For the life science sector, Getinge offers bioreactors, bioprocess control systems, software, analytics, and perfusion systems. Within acute care and surgical environments, its offerings encompass patient monitoring, anesthesia machines, specialized cardiac surgery devices (such as beating heart stabilizers and coronary shunts), ceiling supply units, and connected digital solutions, as well as a variety of cleaning, disinfection, packaging, and sterilization monitoring products. The company also manufactures an extensive range of specialized surgical and critical care items, including various chest drainage systems, endoscopic and endovascular products, extracorporeal life support (ECLS/ECMO) devices, and mechanical ventilators. Additionally, Getinge provides medical furniture, modular operating room systems, surgical lights and tables, OR integration and management tools, patient flow and transport solutions, and comprehensive sterile supply management. It is also a significant supplier of intra-aortic balloon pump therapies, surgical assist systems, perfusion systems, and specialized solutions for vascular and cardiothoracic surgery. Getinge distributes its products worldwide through its proprietary sales companies, as well as a broad network of agents and distributors across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1904, Getinge AB (publ) is headquartered in Gothenburg, Sweden.

Getinge AB (publ) is headquartered in SE.

Getinge AB (publ) (GNGBF) stock trades at $22.49 with a market capitalization of $5.72B. The stock is valued at a price-to-earnings (P/E) ratio of 24.18, price-to-book of 2.09, price-to-sales of 1.89. Over the past 52 weeks the stock has ranged between $20.05 and $24.75, and currently trades 9.1% below its 52-week high. It pays a dividend yielding 2.00%.

On profitability, Getinge AB (publ) generates a return on equity (ROE) of 8.88%, return on capital employed of 10.24%, an operating margin of 13.56%, a net profit margin of 7.82%.

Official website: www.getinge.com